St. John's Wort: The Complete Supplement Guide

Quick Reference Card

Overview

The Basics

St. John's Wort is one of the most studied herbal supplements in the world, with a history of medicinal use stretching back to ancient Greece. The yellow-flowered plant gets its name from John the Baptist, because it typically blooms around the feast of St. John in late June. It has been used for centuries in traditional European medicine as a remedy for headaches, nerve disorders, and melancholy.

Today, St. John's Wort is primarily known for its potential to improve mood and ease symptoms of mild to moderate depression. It is widely prescribed as an antidepressant in several European countries, particularly Germany, where it outsells many conventional prescription antidepressants. In the United States, it is sold as an over-the-counter dietary supplement.

What makes St. John's Wort unusual among herbal supplements is the depth of its research base. Dozens of clinical trials have compared it against both placebos and prescription antidepressants, with many finding it comparably effective to SSRIs for mild to moderate cases. However, this same body of research has revealed a critically important caveat: St. John's Wort interacts with a large number of medications, sometimes in dangerous or life-threatening ways. Understanding both its potential benefits and its interaction risks is essential for anyone considering this supplement [1][2][3].

The Science

Hypericum perforatum L. is a perennial herbaceous plant of the family Hypericaceae, indigenous to Europe, West Asia, and North Africa and now naturalized globally [1]. The species name perforatum refers to the translucent glandular dots visible when the leaves are held to light, which contain essential oils and hypericin [4].

The plant has been classified as an antidepressant herb in modern pharmacological taxonomy, with a research history spanning over three decades of clinical investigation. St. John's Wort is one of the most extensively studied herbal medicines, with active constituents hyperforin and hypericin being the focus of most research [5]. The chemical composition includes naphthodianthrones (hypericin, pseudohypericin, protohypericin), phloroglucinols (hyperforin, adhyperforin), flavonoids (rutin, hyperoside, isoquercetin, quercitrin, quercetin), phenolic acids, and volatile oils [4][6].

Multiple meta-analyses have assessed its efficacy. A 2017 meta-analysis found consistent evidence of antidepressant efficacy for mild to moderate depression [7]. A 2023 meta-analysis comparing St. John's Wort to SSRIs in adults found comparable efficacy with a more favorable side effect profile [8]. The Cochrane Collaboration's systematic review (2008, updated) of 29 trials concluded that St. John's Wort extracts were superior to placebo and similarly effective as standard antidepressants, with fewer side effects and lower dropout rates [9]. However, efficacy data for major or severe depression remain inconsistent [10][11].

Chemical & Nutritional Identity

Common Supplement Forms

Mechanism of Action

The Basics

St. John's Wort works by influencing several brain chemicals at once, which is part of what makes it both effective and potentially risky.

The best-understood mechanism involves three key neurotransmitters: serotonin, norepinephrine, and dopamine. St. John's Wort appears to slow the reuptake (recycling) of all three of these chemicals, which means they stay active in the brain longer. This is similar to how many prescription antidepressants work, though most prescription drugs target only one or two of these neurotransmitters at a time.

The primary active ingredient responsible for this effect is believed to be hyperforin, a compound found in the plant's flowers. Another compound, hypericin, was originally thought to be the main active ingredient, but research has shifted attention toward hyperforin as the more pharmacologically relevant component [5][12].

This multi-target mechanism also explains why St. John's Wort interacts with so many medications. The hyperforin in St. John's Wort activates a protein in the liver called the pregnane X receptor (PXR), which in turn accelerates the production of drug-metabolizing enzymes. This means that many medications get broken down and cleared from the body faster than intended, reducing their effectiveness [13].

The Science

The pharmacological activity of St. John's Wort involves multiple molecular targets:

Monoamine Reuptake Inhibition: In vitro studies demonstrate that hypericum extracts inhibit synaptosomal reuptake of serotonin, norepinephrine, and dopamine [14][15]. While earlier research suggested monoamine oxidase (MAO) inhibition as the primary mechanism, subsequent studies found MAO inhibition to be insignificant at physiologically relevant concentrations [16].

TRPC6 Channel Activation: Hyperforin, the principal phloroglucinol constituent, specifically activates transient receptor potential canonical 6 (TRPC6) channels, inducing neurite outgrowth and influencing monoamine uptake. This represents a novel mechanism distinct from conventional reuptake inhibitors [17].

Oligodendrocyte Function: Hyperforin has been shown to stimulate the development and function of oligodendrocytes, which are responsible for myelination in the central nervous system [18].

Glutamate Modulation: Hypericin suppresses voltage-dependent calcium channel and mitogen-activated protein kinase (MAPK) activity, and evokes glutamate release, providing additional mechanistic pathways for CNS activity [19].

CYP Enzyme Induction: Hyperforin is a potent inducer of cytochrome P450 3A4 (CYP3A4) through activation of the pregnane X receptor (PXR) [13]. St. John's Wort also modulates UDP-glucuronosyltransferase (UGT) and P-glycoprotein (P-gp) activity via protein kinase C signaling [20][21]. This enzyme induction underlies the extensive drug interaction profile.

Neuroprotective Effects: Hyperforin exerts neuroprotective effects through AKT/GSK-3beta signal regulation, reducing aluminum-induced amyloid-beta production and tau phosphorylation in cellular models [22].

Analgesic Activity: Bioflavonoid content and inhibition of protein kinase C isoforms contribute to analgesic and additional CNS activity [23].

Absorption & Bioavailability

The Basics

The bioavailability of St. John's Wort depends substantially on the specific extract and its formulation. Most clinical trials have used standardized extracts that concentrate the active compounds hypericin and hyperforin, allowing for predictable and reproducible dosing.

Taking St. John's Wort with food may improve gastrointestinal tolerability but is not required for absorption. The active compounds are generally well-absorbed when taken orally, though the exact oral bioavailability of individual constituents in humans has not been definitively established.

One important consideration is that different standardized extracts deliver very different amounts of active ingredients. An extract standardized to 0.3% hypericin delivers a very different pharmacological profile than one standardized to 5% hyperforin. This variation between products is one reason why clinical trial results can vary and why not all St. John's Wort products produce the same effects [24].

The Science

Hyperforin is a lipophilic compound, and its absorption follows typical patterns for fat-soluble molecules. Peak plasma concentrations of hyperforin are generally reached within 3-4 hours of oral administration. The elimination half-life of hyperforin has been estimated at approximately 9-12 hours, supporting the common three-times-daily dosing regimen used in clinical trials [24].

Hypericin has a longer half-life, estimated at 24-48 hours, which means it accumulates over days of consistent dosing. This may partially explain why clinical effects typically require 2-4 weeks of consistent use to become apparent [24].

The clinical significance of hyperforin content is underscored by the observation that the extract STW 3-VI, which contains less than 1 mg/day of hyperforin, retains antidepressant activity while producing substantially less CYP3A4 induction than higher-hyperforin extracts [25]. This suggests that antidepressant activity may not be solely attributable to hyperforin, and that other constituents (including hypericin, flavonoids, and other phloroglucinols) contribute to the overall pharmacological effect.

Research & Clinical Evidence

The Basics

The evidence for St. John's Wort is strongest for mild to moderate depression, where it stands out as one of the few herbal supplements with clinical trial data comparable to pharmaceutical antidepressants. Multiple well-designed studies have found it about as effective as prescription SSRIs like fluoxetine, paroxetine, and citalopram, often with fewer side effects and lower dropout rates [3][8][9].

However, the picture is not uniformly positive. For severe or major depression, the evidence is inconsistent, and some well-designed trials have found it no more effective than placebo for these more serious cases [10][11]. This is an important distinction: St. John's Wort appears to have a genuine role in mild to moderate depression but should not be considered a substitute for comprehensive treatment of severe depression.

Beyond depression, research exists for a handful of other conditions. Small studies suggest potential benefits for menopausal hot flashes and premenstrual syndrome, though the evidence base is considerably thinner [26][27]. Studies on ADHD, irritable bowel syndrome, and smoking cessation have not shown clear benefits [2][28].

The Science

Mild to Moderate Depression (Strong Evidence):

A 2017 meta-analysis by Ng et al. analyzing multiple RCTs found that Hypericum perforatum was significantly superior to placebo for depression symptoms [7]. A 2023 meta-analysis by Zhao et al. comparing St. John's Wort to SSRIs in adults confirmed comparable efficacy with a more favorable side effect profile [8].

The Cochrane systematic review (Linde et al., 2008) analyzed 29 trials (5,489 participants) and concluded: "The available evidence suggests that the hypericum extracts tested in the included trials are superior to placebo in patients with major depression, are similarly effective as standard antidepressants, and have fewer side effects than standard antidepressants" [9]. Dropout rates for side effects were significantly lower with St. John's Wort (0.8%) compared to standard antidepressants (3.0%) in included trials.

Clinical comparisons with specific SSRIs include:

• Paroxetine: Hypericum extract WS 5570 showed non-inferiority to paroxetine in moderate depression [29]
• Fluoxetine: Extract ZE 117 demonstrated equivalent efficacy to fluoxetine 20 mg in mild to moderate depression [30]
• Citalopram: Extract STW 3-VI showed comparable efficacy to citalopram with sustained response on continued use [31][32]

Major Depression (Inconsistent Evidence):

The Hypericum Depression Trial Study Group (2002) found St. John's Wort ineffective for major depression of moderate severity in a large NIMH-funded trial, though notably, sertraline (the comparator SSRI) also failed to separate from placebo in the same trial [10]. Rapaport et al. (2011) found St. John's Wort ineffective for minor depression when compared with citalopram [11].

Menopausal Symptoms (Limited Evidence):

A meta-analysis by Liu et al. (2014) suggested that Hypericum perforatum preparations may be helpful for menopausal hot flashes and vasomotor symptoms [26]. A 2019 RCT by Eatemadnia et al. found efficacy for both postmenopausal symptoms and depression [33].

Premenstrual Syndrome (Limited Evidence):

A 2010 RCT by Canning et al. demonstrated efficacy for premenstrual syndrome symptoms [27].

ADHD (Negative Evidence):

A 2008 RCT by Weber et al. found no improvement in ADHD symptoms in children and adolescents [28].

Evidence & Effectiveness Matrix

The matrix below combines clinical evidence strength with community-reported effectiveness to provide a balanced view of St. John's Wort's profile across health domains.

Evidence Strength reflects the quality and volume of clinical trial data. Community-Reported Effectiveness reflects scored sentiment from community discussions. Confidence reflects the reliability of the combined assessment.

Key Observations:

• Mood & Wellbeing has the strongest alignment between clinical evidence and community reports, with Grade A evidence from Examine and consistent community reports of mood improvement
• Motivation and Energy scores are notably higher in community reports than in clinical evidence, reflecting subjective experiences that are not primary endpoints in clinical trials
• Emotional Regulation received a mixed community score due to polarized reports: some users describe improved stability while others describe agitation and irritability suggestive of hypomanic symptoms
• Anxiety scores are moderate; while some clinical trials report anxiolytic effects, this is not the primary studied outcome
• Community data not yet collected for: Focus & Mental Clarity, Memory & Cognition, Libido, Physical Performance, Joint Health, Immune Function

Benefits

The Basics

The primary benefit of St. John's Wort, supported by the strongest evidence, is its ability to improve mood and reduce symptoms of mild to moderate depression. Many people report feeling lighter, more motivated, and more engaged with life after a few weeks of consistent use. Some users also report improvements in anxiety, sleep, and overall energy levels, though these benefits are less consistently documented in clinical research.

St. John's Wort has also shown some promise for reducing menopausal hot flashes and premenstrual symptoms in smaller studies, making it potentially relevant for hormonal symptom management as well [26][27].

It is worth noting that not everyone responds to St. John's Wort. Individual variation in response is a consistent finding across both clinical trials and community reports. Some people experience significant mood improvement, while others notice no effect. This variability is not unusual for psychoactive compounds and may reflect differences in the underlying biology of each person's depression or mood disorder.

The Science

The evidence-based benefit profile of St. John's Wort includes:

Depression symptom reduction: Multiple systematic reviews and meta-analyses confirm statistically significant improvements in depression scores (Hamilton Depression Rating Scale, Beck Depression Inventory) compared to placebo, with effect sizes comparable to standard antidepressants for mild to moderate cases [7][8][9]. The number needed to treat (NNT) is estimated at approximately 4-7 for mild to moderate depression.

Favorable side effect profile: Compared to SSRIs, St. John's Wort consistently demonstrates lower rates of adverse events and lower dropout rates in head-to-head trials [9]. Side effects occurred in approximately 20% of patients on St. John's Wort versus 53% on standard antidepressants in the Cochrane analysis.

Cost-effectiveness: A 2013 economic evaluation found St. John's Wort to be a cost-effective alternative to generic antidepressants for mild to moderate depression [34].

Sustained response: Continuation treatment with Hypericum extract WS 5570 after recovery from an acute depressive episode showed sustained response rates compared to placebo [35].

Neuropathic pain: Preclinical data suggest analgesic properties through hypericin-mediated inhibition of protein kinase C gamma and epsilon activity, though human clinical data on pain outcomes remain limited [23].

When you're taking multiple supplements, it's hard to know which one is doing the heavy lifting. The benefits described above may overlap with effects from other items in your stack, lifestyle changes, or seasonal variation. Doserly helps you untangle that by keeping everything in one place, with timestamps, doses, and outcomes logged together.

Over time, this builds something more valuable than any product review: your personal evidence record. You can see exactly when you started this supplement, what else was in your routine at the time, and how your tracked health markers responded. That clarity makes the difference between guessing and knowing, whether you're talking to a healthcare provider or simply deciding if it's worth reordering.

Side Effects & Safety

The Basics

When taken on its own and at standard doses, St. John's Wort is generally considered well-tolerated. The most commonly reported side effects are mild and include headache, nausea, dry mouth, sleepiness, and stomach discomfort. These tend to occur less frequently than the side effects associated with prescription antidepressants [9].

Photosensitivity (increased sensitivity to sunlight) is a well-known side effect, particularly for fair-skinned individuals. People taking St. John's Wort should be mindful of sun exposure and consider extra sun protection.

However, the most significant safety concern with St. John's Wort is not its direct side effects but its drug interactions. St. John's Wort accelerates the breakdown of many medications in the body, which can reduce their effectiveness to dangerous levels. This includes birth control pills, blood thinners, HIV medications, immunosuppressants, many antidepressants, and several types of cancer treatments. Combining St. John's Wort with other serotonergic compounds (including prescription antidepressants, 5-HTP, and SAM-e) can lead to serotonin syndrome, a potentially life-threatening condition [1][2][5].

There have also been case reports of mania in individuals with underlying bipolar disorder, withdrawal symptoms upon discontinuation, and rare but serious adverse events in individuals taking St. John's Wort alongside other medications [5].

The Science

Common Adverse Effects: Headache, nausea, dry mouth, gastrointestinal upset, and sleepiness occur at rates comparable to or lower than placebo in controlled trials [9]. A systematic review of 35 controlled trials found side effect rates similar to placebo, with no serious adverse events attributable to the herb alone [36].

Photosensitivity: Hypericin-induced phototoxicity is oxygen-dependent and may involve intracellular pH reduction or TNF-related apoptosis pathway activation [37]. Photoactivated hypericin can cause demyelination of cutaneous axons, leading to subacute toxic neuropathy in some cases [38]. Fair-skinned individuals are at higher risk.

Serotonin Syndrome: Co-administration with SSRIs, SNRIs, tricyclic antidepressants, triptans, 5-HTP, or SAM-e carries risk of serotonin syndrome. A case series documented central serotonergic syndrome in 5 elderly patients combining prescription antidepressants with St. John's Wort [39].

Psychiatric Adverse Events: Three case reports document mania in patients with underlying bipolar disorder [40]. Psychosis has been reported as a rare potential contributing factor [41]. These events are more likely in individuals with undiagnosed bipolar spectrum disorders.

Withdrawal: A documented case of withdrawal syndrome (nausea, anorexia, retching, dizziness, dry mouth, thirst, chills, extreme fatigue) occurred after 32 days of use [42]. Community reports corroborate significant rebound depression upon abrupt discontinuation of long-term use.

Hepatotoxicity: Despite widespread use, St. John's Wort has not been convincingly linked to clinically apparent liver injury. The NIH LiverTox database rates its likelihood as "E" (unlikely cause) [6]. However, its effects on CYP450 enzymes may increase or decrease the hepatotoxicity risk of co-administered medications.

Cardiovascular: Isolated case reports include supraventricular tachycardia and cardiovascular collapse during anesthesia, both potentially linked to St. John's Wort use [43][44]. St. John's Wort should be discontinued at least one week before surgery [5].

Managing side effect risks across a multi-supplement stack can feel overwhelming, especially when interactions between supplements, medications, and foods add layers of complexity. Doserly brings all of that into a single safety view so nothing falls through the cracks.

Rather than researching every possible interaction yourself, the app checks your full stack automatically and flags supplement-drug and supplement-supplement interactions that warrant attention. If you do experience something unexpected, logging it takes seconds, and over time the app helps you spot patterns: whether symptoms correlate with specific doses, timing, or combinations. One place for the safety picture that matters most when your stack grows beyond a few bottles.

Dosing & Usage Protocols

The Basics

The most commonly studied dose of St. John's Wort is 300 mg of standardized extract taken three times per day, for a total of 900 mg daily. This is the dosing pattern used in the majority of clinical trials, and it is supported by the pharmacokinetics of hyperforin, which has a relatively short half-life of about 9-12 hours [24].

Most standardized extracts are designed to deliver either 0.3% hypericin or 2-5% hyperforin per dose. These are not interchangeable numbers; they represent different standardization approaches that may produce somewhat different pharmacological profiles.

It typically takes 2 to 4 weeks of consistent daily use before noticeable effects on mood become apparent, which is similar to the timeline for prescription antidepressants [9].

For traditional preparations like teas or tinctures, doses range from 2 to 12.6 grams of dried herb per day, though these provide less predictable levels of active compounds compared to standardized extracts [45].

The Science

Extract-Based Dosing:

Clinical trials have predominantly used 300 mg of standardized extract three times daily (900 mg/day), with most extracts standardized to 0.3% hypericin. Several key clinical trials and their dosing:

Traditional Preparations:

Health Canada monograph specifies 2-12.6 g of dried herb top per day as tea, decoction, or infusion, not to exceed 4.2 g per single dose [45].

Duration Considerations:

Effects typically emerge after 2-4 weeks of consistent use. Most clinical trials run 6-12 weeks. Continuation treatment data (Kasper et al., 2008) support sustained benefit with ongoing use after acute response [35]. Long-term safety data beyond approximately 3 months are limited.

When your stack includes several supplements, each with its own dose, form, and timing requirements, the logistics alone can derail consistency. Doserly consolidates all of it into one protocol view, so every dose across your entire routine is accounted for without spreadsheets or guesswork.

The app also tracks cumulative intake for nutrients that appear in multiple products. If your multivitamin, standalone supplement, and fortified protein shake all contain the same nutrient, Doserly adds them up and shows you the total alongside recommended and upper limits. Managing a thoughtful supplement protocol shouldn't require a degree in nutrition science. The app handles the complexity so you can focus on staying consistent.

What to Expect (Timeline)

Weeks 1-2: Most people will not notice significant mood changes during the first two weeks. Some users report mild early effects such as improved sleep or subtle shifts in energy, but these may reflect placebo expectation. Gastrointestinal side effects, if they occur, tend to appear early and often resolve with continued use.

Weeks 2-4: This is when most clinical trials begin to detect meaningful separation from placebo. Some users report the first signs of mood improvement: lighter mood, more motivation, less emotional reactivity to stressors. Community reports suggest that those who respond tend to notice a gradual "lifting" effect rather than a sudden shift.

Weeks 4-8: Benefits typically consolidate during this period. Clinical trial data show statistically significant improvements in depression scores by weeks 4-6 in most positive trials [9]. Users who are going to respond generally know by this point. Those who see no change after 6-8 weeks of consistent use at adequate doses are unlikely to benefit from continued use.

Weeks 8-12+: Clinical trials typically run 6-12 weeks. Continuation data suggest that benefits are maintained with ongoing use [35]. However, long-term safety data beyond approximately 3 months are limited. Some community reports describe tolerance development or changing response patterns with extended use.

Discontinuation: Based on clinical case reports and community accounts, abrupt discontinuation after extended use may lead to withdrawal-like symptoms or rebound depression. Gradual tapering is commonly recommended by practitioners, similar to the approach used for prescription antidepressants.

Interactions & Compatibility

SYNERGISTIC

• Vitamin D3: Some community reports describe combining SJW with vitamin D supplementation for seasonal mood support. No known pharmacological interaction.
• B-Complex: B vitamins support neurotransmitter synthesis and may complement mood support. No known adverse interaction.

CAUTION / AVOID

Supplements to Avoid:

• 5-HTP: Both affect serotonin levels. Combination increases risk of serotonin excess. Should not be taken together [5].
• L-Tryptophan: Serotonin precursor. Similar serotonin excess risk as 5-HTP.

Medications with Major Interactions:

St. John's Wort has one of the most extensive drug interaction profiles of any supplement. Through CYP3A4 and CYP2C9 induction and P-glycoprotein induction, it reduces the effectiveness of numerous medications:

• Birth control pills: Reduced efficacy, risk of breakthrough bleeding or unintended pregnancy [46]
• SSRIs and SNRIs (fluoxetine, sertraline, paroxetine, citalopram, venlafaxine): Risk of serotonin syndrome [39]
• Tricyclic antidepressants (amitriptyline, imipramine): Serotonin syndrome risk and reduced drug levels [40]
• Triptans (sumatriptan, rizatriptan): Serotonin syndrome risk [40]
• Immunosuppressants (cyclosporine, tacrolimus): Significantly reduced blood levels, risk of transplant rejection [47][48]
• HIV antiretrovirals (indinavir, ritonavir, nevirapine): Reduced drug levels, risk of viral resistance and treatment failure [49][50]
• Anticoagulants (warfarin): Variable effects on INR [51]
• Statins (simvastatin, atorvastatin, rosuvastatin): Increased clearance, reduced efficacy [52]
• Cancer chemotherapy (irinotecan, imatinib, docetaxel): Reduced drug levels [53][54]
• Heart medications (digoxin): P-gp-mediated reduced absorption [55]
• Benzodiazepines and sedatives (alprazolam, zolpidem): Reduced plasma concentrations [56]
• Opioids (oxycodone): Significantly reduced plasma concentrations [57]

Pre-surgical Warning: St. John's Wort should be discontinued at least one week before surgery or chemotherapy due to potential interactions with anesthetic agents and chemotherapy drugs [5].

How to Take / Administration Guide

Recommended forms: Standardized extracts (capsules or tablets) are preferred over whole herb preparations because they deliver more predictable levels of active compounds. Look for extracts standardized to either 0.3% hypericin or 2-5% hyperforin, as these match the formulations used in clinical trials.

Timing considerations: The most common dosing schedule is 300 mg three times daily (with meals). Some once-daily formulations exist (such as STW 3-VI at 900 mg), though the three-times-daily regimen is better supported by pharmacokinetic data given hyperforin's 9-12 hour half-life [24].

With or without food: Taking St. John's Wort with food may improve gastrointestinal tolerability. There is no strong evidence that food substantially alters absorption of the active compounds.

Stacking considerations: St. John's Wort should NOT be combined with any serotonergic supplement (5-HTP, SAM-e, L-tryptophan) or prescription antidepressant. Separate from any interacting medication or supplement. The extensive drug interaction profile means that anyone taking other medications should consult a healthcare professional before starting St. John's Wort.

Cycling guidance: Most clinical trials run 6-12 weeks. There is no established cycling protocol. Some practitioners recommend periodic reassessment of need rather than indefinite use, given the limited long-term safety data. Discontinuation should be gradual rather than abrupt to minimize withdrawal risk.

Tea/infusion preparation: For traditional use, steep 2-4 g of dried flowering tops in boiling water for 5-10 minutes. Traditional preparations deliver less predictable doses of active compounds compared to standardized extracts.

Choosing a Quality Product

Third-party certifications: Look for products verified by USP, NSF International, or ConsumerLab. These certifications confirm that the product contains what the label claims and is free from significant contamination.

Standardization matters: The two most common standardization markers are hypericin (0.3%) and hyperforin (2-5%). Products standardized to one or both of these markers align with the formulations used in clinical trials. Avoid products that do not specify their standardization.

Active vs. cheap forms: Named extracts (LI 160, WS 5570, STW 3-VI, ZE 117) are the formulations actually tested in clinical trials. Generic "St. John's Wort extract" without specified standardization may or may not deliver comparable amounts of active compounds.

Red flags:

• Products claiming to treat or cure depression (this is an illegal drug claim for a dietary supplement)
• No standardization information on the label
• Proprietary blends that hide the actual amount of St. John's Wort extract
• Products combining St. John's Wort with 5-HTP or SAM-e (this combination carries serotonin syndrome risk)

Hyperforin content considerations: Higher hyperforin content is associated with greater CYP3A4 enzyme induction (and therefore greater drug interaction potential). The low-hyperforin extract STW 3-VI was specifically developed to minimize drug interactions while retaining antidepressant activity [25]. For individuals concerned about interaction potential who are not taking interacting medications, this may be a relevant consideration.

Excipient/filler considerations: Standard capsule and tablet excipients are generally not a concern. Look for products free from common allergens (gluten, soy, dairy) if these are relevant to you.

Storage & Handling

St. John's Wort should be stored in a cool, dry place away from direct sunlight. Hypericin is a photosensitive compound, and exposure to light can degrade it over time. Keep containers tightly sealed to protect against moisture.

Shelf life varies by formulation. Standardized extract capsules and tablets typically maintain potency for 2-3 years when properly stored. Liquid extracts and tinctures may have shorter shelf lives; check the expiration date on the product.

Dried herb for tea preparation should be stored in an opaque, airtight container. Freshness matters more for traditional preparations because unstandardized herb may lose potency faster than concentrated extracts.

Lifestyle & Supporting Factors

Dietary considerations: While St. John's Wort is not a nutrient found in food, a balanced diet rich in B vitamins, omega-3 fatty acids, vitamin D, and magnesium may support the neurochemical pathways involved in mood regulation. These nutrients are foundational for neurotransmitter synthesis.

Exercise: Regular physical activity has strong independent evidence for mood improvement and depression management. Exercise may complement the effects of St. John's Wort and is frequently recommended alongside any mood support intervention.

Sleep: Adequate sleep is essential for mood regulation. St. John's Wort may have mild sleep-supportive effects for some individuals, but it is not a sleep aid. Addressing sleep hygiene fundamentals (consistent bedtime, dark environment, limiting screen time) is important for anyone managing mood concerns.

Sun exposure: Due to the photosensitivity risk associated with St. John's Wort (particularly with higher doses or fair skin), sun protection measures are advisable. Use broad-spectrum sunscreen, wear protective clothing, and avoid prolonged sun exposure or tanning beds while supplementing [37][38].

Alcohol: Some community reports describe altered alcohol tolerance while taking St. John's Wort. Alcohol may increase sedation and should be used cautiously.

Monitoring: Because St. John's Wort has the pharmacological profile of an antidepressant, its use warrants the same level of self-monitoring. Track mood changes, sleep patterns, energy levels, and any side effects. If depressive symptoms worsen, new psychiatric symptoms emerge (irritability, agitation, racing thoughts), or if you develop skin sensitivity to sunlight, consult a healthcare professional.

Regulatory Status & Standards

United States (FDA): St. John's Wort is regulated as a dietary supplement under DSHEA. It is not approved by the FDA as a treatment for depression or any other condition. It does not require a prescription.

Canada (Health Canada): St. John's Wort has a Natural Health Product monograph (Hypericum perforatum, oral). Licensed products carry an NPN (Natural Product Number). Approved claims include helping relieve restlessness/nervousness, promoting healthy mood balance, and helping relieve sleep disturbances associated with mood imbalance [45].

European Union (EFSA/EMA): The European Medicines Agency Committee on Herbal Medicinal Products (HMPC) has published a formal monograph on Hypericum perforatum L., herba (Revision 1, November 2022), recognizing both well-established use for mild to moderate depression and traditional use for mood disturbance, restlessness, and anxiety [58]. St. John's Wort is widely prescribed as a licensed medicine in Germany and several other European countries.

Australia (TGA): Available as a listed complementary medicine.

Athlete & Sports Regulatory Status:

• WADA: St. John's Wort is not on the WADA Prohibited List. However, athletes should be aware that its CYP3A4 induction effects could alter the metabolism of other substances, potentially affecting drug test interpretation.
• NCAA/Professional Leagues: Not a banned substance in any major professional sports league or the NCAA. However, athletes should verify the current status with their sport's governing body.
• Athlete Certification Programs: Informed Sport and NSF Certified for Sport certified products may be available. Athletes should look for these certifications to minimize contamination risk.
• GlobalDRO: Athletes can check supplement status at GlobalDRO.com across US, UK, Canada, Australia, Japan, Switzerland, and New Zealand.

Regulatory status and prohibited substance classifications change frequently. Athletes should always verify the current status of any supplement with their sport's governing body, their national anti-doping agency, and a qualified sports medicine professional before use. Third-party certification (Informed Sport, NSF Certified for Sport) reduces but does not eliminate the risk of contamination with prohibited substances.

Frequently Asked Questions

Is St. John's Wort as effective as prescription antidepressants?
Based on available clinical data, St. John's Wort appears comparably effective to SSRIs for mild to moderate depression, with meta-analyses showing similar response rates and lower side effect profiles [8][9]. However, for severe or major depression, the evidence is inconsistent, and prescription medications remain the standard of care. Anyone managing depression should work with a healthcare professional to determine the most appropriate treatment.

Can I take St. John's Wort with my antidepressant?
No. Combining St. John's Wort with prescription antidepressants (SSRIs, SNRIs, tricyclics, MAOIs) creates a risk of serotonin syndrome, a potentially life-threatening condition characterized by agitation, confusion, rapid heartbeat, high blood pressure, and muscle rigidity [5][39]. If you are considering switching from a prescription antidepressant to St. John's Wort (or vice versa), this should only be done under medical supervision with an appropriate washout period.

Does St. John's Wort affect birth control?
Yes. St. John's Wort can reduce the effectiveness of hormonal contraceptives (birth control pills, patches, rings) by accelerating their metabolism through CYP3A4 induction. This can lead to breakthrough bleeding or unintended pregnancy [46]. If you are using hormonal contraception, consult your healthcare provider before taking St. John's Wort.

How long does it take to start working?
Most clinical trials show effects emerging after 2-4 weeks of consistent daily use. Some community reports describe earlier onset, but this may reflect placebo expectation. If no benefit is noticed after 6-8 weeks of consistent use at adequate doses, the supplement is unlikely to be effective for that individual.

Is St. John's Wort safe during pregnancy or breastfeeding?
St. John's Wort is not recommended during pregnancy or breastfeeding. Safety data for these populations are insufficient, and clinical sources advise against use [5][45].

Can St. John's Wort cause mania?
Case reports document mania in individuals with underlying bipolar disorder [40]. People with a personal or family history of bipolar disorder, hypomania, or psychosis should exercise particular caution and consult a psychiatrist before considering St. John's Wort.

Does St. John's Wort cause sun sensitivity?
Yes. Photosensitivity is a well-documented side effect, particularly at higher doses and in fair-skinned individuals [37][38]. Sun protection is advisable while taking St. John's Wort.

What happens if I stop taking St. John's Wort suddenly?
Withdrawal symptoms have been reported after abrupt discontinuation of extended use, including nausea, dizziness, dry mouth, fatigue, and rebound depression [42]. Gradual tapering under healthcare guidance is recommended, similar to the approach used for prescription antidepressants.

Are all St. John's Wort products the same?
No. Different products contain different extracts with varying levels of hypericin and hyperforin. The named extracts used in clinical trials (LI 160, WS 5570, STW 3-VI, ZE 117) are specifically characterized formulations. Generic products may or may not deliver comparable amounts of active compounds.

How does St. John's Wort interact with medications?
St. John's Wort induces CYP3A4, CYP2C9, and P-glycoprotein, which accelerates the metabolism and clearance of many drugs. This can reduce the blood levels and effectiveness of numerous medications including oral contraceptives, immunosuppressants, antiretrovirals, anticoagulants, statins, and many others [5][13][20]. Always inform your healthcare providers if you are taking St. John's Wort.

Myth vs. Fact

Myth: St. John's Wort is "just an herb" and has no real drug-like effects.
Fact: St. John's Wort contains compounds that inhibit the reuptake of serotonin, norepinephrine, and dopamine, making it pharmacologically comparable to some prescription antidepressants [14][15]. It is one of the most drug-interactive supplements known, affecting multiple cytochrome P450 enzyme systems and drug transporters [13][20]. Treating it as benign because it is "natural" is a serious safety error.

Myth: St. John's Wort works for all types of depression.
Fact: Clinical evidence supports its use for mild to moderate depression only. Multiple well-designed trials have found it ineffective for major or severe depression [10][11]. It is not an appropriate substitute for comprehensive treatment of severe depressive disorders.

Myth: You can take St. John's Wort alongside your prescription medications without issue.
Fact: St. John's Wort has one of the most extensive drug interaction profiles of any supplement, affecting dozens of medications through enzyme induction. Interactions can be dangerous or life-threatening, particularly with immunosuppressants, antiretrovirals, and serotonergic drugs [5][47][49].

Myth: St. John's Wort works immediately.
Fact: Like prescription antidepressants, St. John's Wort typically requires 2-4 weeks of consistent use before mood benefits become apparent [9]. Immediate effects reported by some users may reflect placebo response.

Myth: Hypericin is the primary active ingredient.
Fact: While early research focused on hypericin, current evidence points to hyperforin as the more pharmacologically significant compound for antidepressant activity. However, the full picture is complex: low-hyperforin extracts (STW 3-VI) still demonstrate antidepressant activity, suggesting multiple constituents contribute to the overall effect [24][25].

Myth: St. John's Wort has no withdrawal effects because it is natural.
Fact: Withdrawal symptoms have been documented after abrupt discontinuation, including nausea, dizziness, fatigue, and rebound depression [42]. Gradual tapering is recommended, similar to the approach used for prescription antidepressants.

Myth: All St. John's Wort supplements are equivalent.
Fact: Significant variation exists between products in terms of extract type, standardization markers, and levels of active compounds. Clinical trial results are specific to named extracts (LI 160, WS 5570, etc.) and may not generalize to all commercially available products.

Sources & References

Systematic Reviews & Meta-Analyses

[7] Ng QX, Venkatanarayanan N, Ho CY. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis. J Affect Disord. 2017;210:211-221. https://pubmed.ncbi.nlm.nih.gov/28033549/

[8] Zhao X, Zhang H, Wu Y, et al. The efficacy and safety of St. John's wort extract in depression therapy compared to SSRIs in adults: a meta-analysis of randomized clinical trials. Adv Clin Exp Med. 2023;32(2):151-161.

[9] Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008;(4):CD000448. https://pubmed.ncbi.nlm.nih.gov/18843608/

[26] Liu YR, Jiang YL, Huang RQ, et al. Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety. Climacteric. 2014;17(4):325-335.

[36] Knuppel L, Linde K. Adverse effects of St. John's Wort: a systematic review. J Clin Psychiatry. 2004;65:1470-1479. https://pubmed.ncbi.nlm.nih.gov/15554758/

Clinical Trials & RCTs

[10] Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287(14):1807-1814. https://pubmed.ncbi.nlm.nih.gov/11939866/

[11] Rapaport MH, Nierenberg AA, Howland R, et al. The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo. J Psychiatr Res. 2011;45(7):931-941.

[27] Canning S, Waterman M, Orsi N, et al. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010;24(3):207-225.

[28] Weber W, Vander Stoep A, McCarty RL, et al. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA. 2008;299(22):2633-2641.

[29] Szegedi A, Kohnen R, Dienel A, et al. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 2005;330(7490):503.

[30] Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol. 2000;15(2):61-68.

[31] Gastpar M, Singer A, Zeller K. Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. Pharmacopsychiatry. 2006;39(2):66-75.

[32] Singer A, Schmidt M, Hauke W, et al. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis. Phytomedicine. 2011;18(8-9):739-742.

[33] Eatemadnia A, Ansari S, Abedi P, et al. The effect of Hypericum perforatum on postmenopausal symptoms and depression: a randomized controlled trial. Complement Ther Med. 2019;45:109-113.

[35] Kasper S, Volz HP, Moller HJ, et al. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression: a double-blind, randomized, placebo controlled long-term trial. Eur Neuropsychopharmacol. 2008;18(11):803-813.

Government & Institutional Sources

[1] NCCIH. St. John's Wort: Usefulness and Safety. National Center for Complementary and Integrative Health, National Institutes of Health. https://www.nccih.nih.gov/health/st-johns-wort

[2] NCCIH. St. John's Wort and Depression: In Depth. National Center for Complementary and Integrative Health, National Institutes of Health. https://www.nccih.nih.gov/health/st-johns-wort-and-depression-in-depth

[45] Health Canada. Natural Health Product Monograph: Hypericum perforatum (St. John's wort), oral. Natural and Non-prescription Health Products Directorate.

[58] European Medicines Agency (EMA). European Union herbal monograph on Hypericum perforatum L., herba. Final, Revision 1. EMA/HMPC/7695/2021. November 23, 2022.

Pharmacology & Mechanism Studies

[4] Barnes J, Anderson LA, Phillipson JD. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2001;53(5):583-600.

[5] Memorial Sloan Kettering Cancer Center. St. John's Wort. About Herbs Database. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/st-john-wort

[6] NIH LiverTox. St. John's Wort. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. NIDDK. https://www.ncbi.nlm.nih.gov/books/NBK548880/

[12] Nobakht SZ, Akaberi M, Mohammadpour AH, et al. Hypericum perforatum: traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci. 2022;25(9):1045-1058.

[13] Godtel-Armbrust U, Metzger A, Kroll U, et al. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort. Naunyn Schmiedebergs Arch Pharmacol. 2007;375(6):377-382.

[14] Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res. 1999;816(2):358-363.

[15] Franklin M, Chi J, McGavin C, et al. Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers. Biol Psychiatry. 1999;46(4):581-584.

[16] Yu PH. Effect of the Hypericum perforatum extract on serotonin turnover in the mouse brain. Pharmacopsychiatry. 2000;33(2):60-65.

[17] Leuner K, Kazanski V, Muller M, et al. Hyperforin, a key constituent of St. John's wort, specifically activates TRPC6 channels. FASEB J. 2007;21(14):4101-4111.

[18] Wang Y, Zhang Y, He J, et al. Hyperforin promotes mitochondrial function and development of oligodendrocytes. J Neurochem. 2011;119(3):555-568.

[19] Chang Y, Wang SJ. Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes. Eur J Pharmacol. 2010;634(1-3):53-61.

[20] Volak LP, Court MH. Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions. Xenobiotica. 2010;40(5):306-318.

[21] Ott M, Huls M, Cornelius MG, et al. St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier. Pharm Res. 2010;27(5):811-822.

[22] Huang W, Cheng P, Yu K, et al. Hyperforin attenuates aluminum-induced amyloid-beta production and tau phosphorylation via regulating Akt/GSK-3beta signaling pathway in PC12 cells. Biomed Pharmacother. 2017;96:1-6.

[23] Galeotti N, Vivoli E, Bilia AR, et al. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of protein kinase C gamma and epsilon activity. Biochem Pharmacol. 2010;79(9):1327-1336.

[24] Soleymani S, Bahramsoltani R, Rahimi R, et al. Clinical risks of St John's wort (Hypericum perforatum) co-administration. Expert Opin Drug Metab Toxicol. 2017;13(10):1047-1062.

[25] Nicolussi S, Drewe J, Butterweck V, et al. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020;177(6):1212-1226.

[34] Solomon D, Adams J, Graves N. Economic evaluation of St. John's wort for the treatment of mild to moderate depression. J Affect Disord. 2013;148(2-3):228-234.

Drug Interaction Studies

[37] Kiesslich T, Krammer B, Plaetzer K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem. 2006;13(18):2189-2204.

[38] Bove GM. Acute neuropathy after exposure to sun in a patient treated with St John's Wort. Lancet. 1998;352(9134):1121-1122.

[39] Lantz MS, Buchalter E, Giambanco V. St. John's wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol. 1999;12(1):7-10.

[40] Parker V, Wong AH, Boon HS, et al. Adverse reactions to St John's Wort. Can J Psychiatry. 2001;46(1):77-79.

[41] Ferrara M, Mungai F, Starace F. St John's wort (Hypericum perforatum)-induced psychosis: a case report. J Med Case Rep. 2017;11(1):137.

[42] Dean AJ, Moses GM, Vernon JM. Suspected withdrawal syndrome after cessation of St. John's wort. Ann Pharmacother. 2003;37(1):150.

[43] Fisher KA, Patel P, Abualula S, et al. St. John's Wort-Induced Supraventricular Tachycardia. Cureus. 2021;13(4):e14356.

[44] Irefin S, Sprung J. A possible cause of cardiovascular collapse during anesthesia: long-term use of St. John's Wort. J Clin Anesth. 2000;12(6):498-499.

[46] Hohmann N, Maus A, Carls A, et al. St. John's wort treatment in women bears risks beyond pharmacokinetic drug interactions. Arch Toxicol. 2016;90(4):1013-1015.

[47] Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to Saint John's wort. Lancet. 2000;355(9203):548-549.

[48] Breidenbach T, Hoffmann MW, Becker T, et al. Drug interaction of St John's wort with cyclosporin. Lancet. 2000;355(9218):1912.

[49] Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John's wort. Lancet. 2000;355(9203):547-548.

[50] de Maat MM, Hoetelmans RM, Matot RA, et al. Drug interaction between St John's wort and nevirapine. AIDS. 2001;15(3):420-421.

[51] Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004;57(5):592-599.

[52] Eggertsen R, Andreasson A, Andren L. Effects of treatment with a commercially available St John's Wort product on cholesterol levels in patients treated with simvastatin. Scand J Prim Health Care. 2007;25(3):154-159.

[53] Mathijssen RH, Verweij J, de Bruijn P, et al. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst. 2002;94(16):1247-1249.

[54] Smith P, Bullock JM, Booker BM, et al. The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate. Pharmacotherapy. 2004;24(11):1508-1514.

[55] Gurley BJ, Swain A, Williams DK, et al. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions. Mol Nutr Food Res. 2008;52(7):772-779.

[56] Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290(11):1500-1504.

[57] Nieminen TH, Hagelberg NM, Saari TI, et al. St John's wort greatly reduces the concentrations of oral oxycodone. Eur J Pain. 2010;14(8):854-859.

Review Articles

[3] Apaydin EA, Maher AR, Shanman R, et al. A systematic review of St. John's wort for major depressive disorder. Syst Rev. 2016;5(1):148.

Related Supplement Guides

Same Category (Herbal, Cognitive/Nootropic)

• Bacopa Monnieri
• Ginkgo Biloba
• Gotu Kola
• Lemon Balm
• Passionflower
• Valerian Root
• Mucuna Pruriens

Interaction-Related (AVOID combining)

• 5-HTP
• L-Tryptophan

Related Health Goal (Mood Support)

• Ashwagandha
• Rhodiola Rosea
• L-Theanine
• Magnesium
• Vitamin D3
• Fish Oil (EPA/DHA)
• B-Complex
• GABA
• Inositol